Health & Fitness
Health and Fitness
Health and Fitness
Wed, June 30, 2010
Tue, June 29, 2010 Bond's NDS Division Releases Embracea" Weight Loss Kit for $58 Billion Weight Loss Market
OMAHA, Neb.--([ BUSINESS WIRE ])--Bond Laboratories, Inc. (OTCBB:BNLB), an innovative manufacturer of functional beverages and nutritional products, today announced that its NDS Nutrition division has released the Embracea" Weight Loss Kit. Targeting weight loss, toning and full body detox, the ground-breaking formula and packaging of Embracea" is unparalleled in the industry. Embracea" is a highly differentiated premium weight loss product in the $58 billion U.S. market for weight reduction and dieting, as reported by Marketdata, Inc. The product also increases energy and promotes healthy metabolism. Initial shipments commenced in early April 2010.
"What makes Embracea" unprecedented in the industry is its unique three component program that addresses multiple dieting goals at the same time"
aWhat makes Embracea" unprecedented in the industry is its unique three component program that addresses multiple dieting goals at the same time,a commented Pat Ryan, VP Retail Sales at NDS. aWhile promoting a healthy alternative to weight loss, the Embracea" 6-week program will also increase energy, help muscle tone, and support cleaning the body of impurities.a
aThe launch of Embracea" continues NDSa™ long-standing tradition of developing high-quality dietary supplements,a stated Bond Labs CEO, John S. Wilson. aInitial market feedback for Embracea" has been extremely positive and we look forward to delivering the product to GNC® franchisees.a
About Bond Labs
Bond Laboratories is a manufacturer of innovative nutritional supplements and beverages. The Company produces and markets products through its NDS Nutrition and Fusion Premium Beverages divisions. NDS nutritional supplements are among the most popular products sold in GNC® franchise retail stores. Fusion Premium Beverages manufactures functional beverages, including the highly successful hangover prevention drink Resurrectiona". Bond is headquartered in Omaha, Nebraska and maintains its primary sales operations in Dallas, TX. For more information on the Company please go to [ http://www.bond-labs.com ].
Safe Harbor
Statements about the Company's future expectations and all other statements in this press release other than historical facts, are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby.
The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. The company does not undertake any responsibility to update the forward-looking statements contained in this release.
